Open Access

Summary and key messages - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

logo

Congress Presentation

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
92 presentations
9 followers

5 more presentations in this session

Welcome and introduction - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Non-vitamin K antagonist oral anticoagulants in cardioversion: the ENSURE-AF study.

Speaker: Professor A. Goette (Paderborn, DE)

Thumbnail

Update from ENGAGE AF-TIMI 48: clinical implications.

Speaker: Doctor R. Giugliano (Boston, US)

Thumbnail

Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines.

Speaker: Professor H. Heidbuchel (Antwerp, BE)

Thumbnail

Panel discussion - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA) Professor G. Lip (Liverpool, GB) Doctor R. Giugliano (Boston, US) Professor A. Goette (Paderborn, DE) Professor H. Heidbuchel (Antwerp, BE)

Thumbnail

Access the full session

Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications

Speakers: Professor G. Lip, Doctor J. Weitz, Professor A. Goette, Doctor R. Giugliano, Professor H. Heidbuchel...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb